Sign in

CIK 0001396814 · Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
510619477
Phone
650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
  1. 4 Open-market sale Director sold 500 shares at $21.81 ($10,905)
  2. 4 Grant or award Chief Financial Officer acquired 49,091 shares (grant or award)
  3. 4 Grant or award Chief Administrative Officer acquired 54,546 shares (grant or award)
  4. 4 Grant or award Chief Commercial Officer acquired 51,714 shares (grant or award)
  5. 4 Grant or award Senior Vice President, Finance acquired 19,273 shares (grant or award)
  6. 4 Grant or award Chief Medical Officer acquired 54,546 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 261,818 shares (grant or award)
  8. 4 Planned sale Senior Vice President, Finance sold 4,000 shares at $20.81 ($83,240)
  9. 4 Planned sale Chief Administrative Officer sold 13,137 shares at $20.53 ($269,703)
  10. 4 Shares withheld for taxes Chief Medical Officer gave up 6,168 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Commercial Officer gave up 5,182 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 41,488 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 381 shares (to pay taxes)
  16. 4 Planned sale Senior Vice President, Finance sold 1,416 shares at $24.24 ($34,324)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 9,272 shares (to pay taxes)
  18. 4 Grant or award Chief Commercial Officer acquired 402.27 shares (grant or award)
  19. 4 Planned sale Chief Financial Officer sold 25,000 shares at an average $25.07 ($626,751)
  20. 4 Planned sale Chief Medical Officer sold 3,960 shares at $24.09 ($95,396)

Page 2 of 35 · 695 filings